Brief Biography:
Olorunfemi Abraham Eseyin is currently a Professor in the department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmacy, University of Uyo, Nigeria. He holds a B.Sc degree in Biochemistry, M.Sc degree in Pharmaceutical Chemistry and PhD degree in Clinical Biochemistry obtained from the Universities of Sokoto, Lagos and Calabar in Nigeria, respectively.He has been an academic staff in the University of Uyo, Nigeria since 1994. His major research focus is food-drug interactions and phytotherapy of diabetes. He is a member of the following learned societies: Nigerian Society of Biochemistry and Molecular Biology (Nigeria), Nigeria Society for Experimental Biology (Nigeria), The Endocrine Society (USA), International Society for Ethnopharmacology (UK), Biochemical Society (UK), Society for Environmental Toxicology and Chemistry (SETAC, Europe) and Indian Society for Chemists and Biochemists (India). He is a Technical editor of scientific journals such as: Asian Journal of Biochemistry, International Journal of Pharmacology, Journal of Pharmacology and Toxicology, Research Journal of Medicinal Plant, American Journal of Biochemistry and Molecular Biology etc and Reviewer to many journals such as: Macedonian Journal of Medical Sciences, Journal of Medicinal Plant Research etc. He is a grantee of the International Foundation of Science (Sweden)-Individual (011) and collaborative (2015) research grants and a USM-TWAS postdoctoral fellow. He has supervised Bachelors of Pharmacy students' project, M.Sc and PhD students research in Pharmaceutical and Medicinal Chemistry.
Academic positions:
Professor, Department of Pharmaceutical and Medicinal Chemistry, University of Uyo, Nigeria.
Research interests:
1. Pharmacokinetics (Effect of food on the effectiveness of antimalaria drugs).2. Screening of Medicinal Plants for antidiabetic activity.3. Development of plant drugs for treatment of diabetes.4. Natural Products.
What I think of the idea behind WebmedCentral:
The idea is excellent and laudable.
All site content, except where otherwise noted, is licensed under a
Creative Commons Attribution License